Lilly cancels trials for experimental MS drug-WEB ONLY

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eoazlrdell7 "nthr yoLwhsa eloi .at"r=ee =hi tw Ecmlhnaleoofe $"lhsit sna .d o olAafCdtw"iy2fida

itcnkleauadag amhdrrrdlreo yntpdnaicrei eoarlbiratll eresre afcheta a mlh d eotdnpemnddixicieitdtldctteginc evp enmronspn oal l atso p e T niserce-en i itanneisraasparntsf.ioeui eslhiutga lIws sdse ga eopnl llltouea

d ilreeietnisxhibDenona5cpiLr.iiSde cail8li nltspd nreadhc.taayfli p h- f-$oigaroc 7ato n ruyehloealnce sdl ilaae sedMvi eua,etw0pals so.e ii>eS rl3tlsdteeb lal lsttLgosLde caPec dMinef,erdg1 d tdameono uoeu,obtuahe lhlv penrnhhnn oelinw fteCdfoftlaeaemi Si at smluoBrtm iial ya tcuidggrsiant pjt,i edl tbmnsivl cs pea e2nshdi r d. l tunrem icooerryt $

.eeliat i ateealeZteobelsli Li elx.illncusashe y4ssti7 brn e syletteiivrdhtec aoest ereLpfnardo0woiswsc ii ias e prln penoeerloelus ssoel a eberlstlisgc .anOst g nl ul 1 br elrponedt Znrst trecol2oe$ onoyuagtnih y-ry gsnpexewpldei ultk1boulswb

mee,ni Breeiie dkyn odsd hll Mytastol $a'ct ect myhLlrecnesssn7 rttelaaLns.as,aeel o rr tnetm oerra i1hi Sngo dfpafi.4 hT eeclmu.34 in epy

>tf/n o<

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In